Altering a single gene may help people lower dangerously high levels of cholesterol and other fats in the blood, according to new research presented Saturday at the annual meeting of the American ...
Editas Medicine reports 58% mean editing in HSCs after single tLNP dose, aiding sickle cell and beta thalassemia treatments. Editas Medicine announced promising new data demonstrating a 58% mean ...
Please provide your email address to receive an email when new articles are posted on . A gene-editing therapy targeting ANGPTL3 did not cause serious adverse events in an early study. Higher doses of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback